Notice: Fall 2017 exams affected by natural disasters... More >

Expand/Collapse Close

ABIM knows that we have many physicians whose lives have been upended by recent natural disasters. If you live or work near an affected area, we understand that the weather may have impacted your ability to take your Fall 2017 exam as scheduled. We have developed a series of options to help you get through this process as smoothly as possible. If you have any questions, please call us at 1-800-441-ABIM (2246) or email request@abim.org.

American Board of Internal Medicine home page

MOC is a professionally determined standard that attests that an internist is staying current in knowledge and practice throughout his/her career.

Initial Certification indicates that physicians have met rigorous standards through intensive study, accredited training and evaluation and that they have the clinical judgment, skills and attitudes essential for the delivery of excellent patient care.

For more than 75 years, Certification by ABIM has stood for the highest standard in internal medicine and its 20 subspecialties.

ABIM Council

Jeanne M. Marrazzo, MD, MPH, Chair

Dr. Marrazzo is Professor of Medicine and Director of the Division of Infectious Diseases at the University of Alabama at Birmingham. She is internationally recognized for her research and education efforts in the field of sexually transmitted infections, especially as they affect women's health. She is a Fellow of the American College of Physicians and of the Infectious Diseases Society of America. Dr. Marrazzo is the Chair of the American Board of Internal Medicine (ABIM) Council, and also chairs the ABIM Infectious Disease Specialty Board. She is board certified in Infectious Disease.

She conducts research on the human microbiome, specifically as it relates to female reproductive tract infections and hormonal contraception. Her other research interests include the prevention of HIV infection using biomedical interventions, including microbicides. Recently, Dr. Marrazzo led the VOICE Study, a large study evaluating HIV pre-exposure prophylaxis administered vaginally and orally to women at high risk for HIV infection in sub-Saharan Africa conducted by the NIH-funded Microbicide Trials Network.

Other areas of research interest include pathogenesis and management of bacterial vaginosis; STD in HIV-infected persons; and management of antibiotic resistance in gonorrhea.

Dr. Marrazzo obtained her undergraduate degree from Harvard and Radcliffe College and medical degree from Jefferson Medical College. She completed residency training and chief residency in internal medicine at Yale-New Haven Hospital. She obtained a master's degree in public health degree in epidemiology at the University of Washington in 1994, where she also completed a fellowship in infectious diseases.

As of January 2017, Dr. Marrazzo reported the following external relationships:

Funding for clinical trial expenses and staff, paid to the University of Washington, from the following companies:

  • Curatek Pharmaceuticals, providing funding for a trial of treatment of vaginal infections.
  • UpToDate, receiving royalties as content author and peer reviewer.

Dr. Marrazzo serves in significant roles with the following organizations, receiving compensation for travel reimbursement:

  • Anaerobe Society of the Americas, Board of Directors, Member, without compensation.
  • Guttmacher Institute, Board of Directors, Member; Nominating Committee, Chair, receiving reimbursement for travel expenses.
  • International Antiviral Society-USA, Board of Directors, Member, receiving reimbursement for travel expenses.
  • The International Society for Sexually Transmitted Diseases Research, Board of Directors, President, without compensation.

Olakunle Akinboboye, MD

Dr. Akinboboye is board certified in Cardiovascular Disease and Sleep Medicine. He is an Associate Professor of Clinical Medicine at the Weill Medical College of Cornell University, New York. He is also the Medical Director of Queens Heart Institute/Laurelton Heart Specialist P.C. in Rosedale, Queens, New York.

Dr. Akinboboye is Chair of the American Board of Internal Medicine Cardiovascular Board and a member of the ABIM Council. He is also a member of the Association of Black Cardiologists (ABC) Executive Committee, where he serves as Chair of the Clinical Trials Committee. He also serves on the International Board of Governors of the American College of Cardiology (Liason for Africa). He served as the President of the ABC from 2012 to 2014.

He received a humanitarian award from the College of Medicine at University of Ibadan in Nigeria in 2005 for his ongoing efforts to spread expertise in the techniques of cardiopulmonary resuscitation in Nigeria. He also received an award from ABC for his dedicated service as a board member from 1999 to 2005.

Dr. Akinboboye received his medical degree from the College of Medicine at the University of Ibadan. He completed his internal medicine residency and part of his cardiology fellowship at the Nassau County Medical Center, State University of New York at Stony Brook. He subsequently moved to Columbia University, where he completed his fellowship in cardiology with one year of dedicated training in nuclear cardiology and another year of training in advanced echocardiography. Dr. Akinboboye obtained a master's degree in public health from Columbia University. He also received a master’s degree in business administration from Columbia Business School.

As of January 2017, Dr. Akinboboye reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Queens Heart Institute, from the following companies:

  • AstraZeneca, for a study of the effects of exenatide in lowering cardiovascular events in patients with type 2 diabetes mellitus (EXSCEL).
  • Novartis, for a study of the effectiveness of angiotensin-neprilysin inhibition versus enalapril in heart failure (PARADIGM-HF).

Service on a research-related expert panel or advisory board, paid to Queens Heart Institute, for the following companies, with compensation as listed:

  • Alnylam Pharmaceuticals, Inc., to advise on a study of ALN-TTRsc, a novel RNA interference therapeutic for the treatment of familial amyloidotic cardiomyopathy, receiving travel reimbursement and honoraria.

Teaching in satellite symposia funded by the following companies, with compensation as listed:

  • Arbor Pharmaceuticals, for a discussion of the use of fixed-dose isosorbide dinitrate/hydralazine in the management of self-identified black patients with congestive heart failure and management of hypertension with EDARBI/EDARBYCLOR, receiving honoraria.
  • Arbor Pharmaceuticals, for teaching on the management of hypertension with azilsartan medoxomil and azilsartan medoxomil plus chlorthalidone, receiving honoraria.
  • Takeda, for teaching about the management of type 2 diabetes with alogliptin, receiving honoraria.

Jeffrey S. Berns, MD

Dr. Berns is Professor of Medicine and Pediatrics at the Perelman School of Medicine at the University of Pennsylvania, where he is Associate Dean for Graduate Medical Education, Associate Chief of the Renal, Electrolyte, and Hypertension Division, and Director of the Nephrology Fellowship Training Program. Dr. Berns maintains a general nephrology practice at the Hospital of the University of Pennsylvania. He is a board certified internist and nephrologist.

Dr. Berns was in private practice, first in Northern Virginia, then in Philadelphia, for about 12 years before joining the faculty of the University of Pennsylvania in 1999.

Dr. Berns serves as Dialysis Section co-Editor for UpToDate, and is Co-Deputy Editor of American Journal of Kidney Diseses. He is Chair of the American Board of Internal Medicine (ABIM)'s Nephrology Board and Chair-Elect of the ABIM Council. He also served on the ABIM Nephrology Board Exam Committee and the ABIM Nephrology Self-Assessment Committee. He is Immediate Past President of the National Kidney Foundation. He has received numerous teaching awards, including the Christian R. and Mary F. Lindback Award for Distinguished Teaching from the University of Pennsylvania. He is also the recipient of the Exemplar of Humanism in Medicine Award from the College of Physicians of Philadelphia. He has been regularly honored in Philadelphia Magazine as a “Philadelphia Top Doc” and as one of America's “Top Docs” in nephrology.

Dr. Berns received his medical degree from Case Western Reserve University in Cleveland, Ohio. He completed his internal medicine internship at University Hospitals of Cleveland and then his nephrology fellowship at Yale University.

As of January 2017, Dr. Berns reported the following external relationships:

Service on a research-related expert panel or advisory board for the following company, with compensation as listed:

  • Amgen, serving as an Executive Committee member for a clinical trial of darbepoetin, receiving hourly compensation.

Work as an author or editor for following companies, with compensation as listed:

  • McGraw-Hill, receiving compensation for serving as a book editor.
  • UpToDate, receiving compensation for authorship and editorial services.

Dr. Berns serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • National Kidney Foundation, serving as past President, receiving reimbursement for travel expenses.

Marcy B. Bolster, MD

Dr. Bolster is an Associate Professor of Medicine at Harvard Medical School. She is the Director of the rheumatology fellowship training program in the Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital (MGH). She is a board certified rheumatologist.

Prior to her position at MGH, she was a Professor of Medicine, Division of Rheumatology, at the Medical University of South Carolina (MUSC), where she was on faculty from 1993-2012. She also served as the Director of the rheumatology fellowship training program; the Medical Director of the Center for Osteoporosis and Bone Health and the Medical Director of the Musculoskeletal Institute at MUSC.

She is a fellow of the American College of Physicians and of the American College of Rheumatology (ACR), a member of the International Society for Clinical Densitometry and a member of the American Society for Bone Mineral Research. She is Chair, ACR Committee on Training and Workforce (COTW). She has served as co-leader for the ACR in the ACGME Next Accreditation System. She is a member of both the ACR and the Rheumatology Research Foundation Boards of Directors. She has served on the American Board of Internal Medicine (ABIM) Rheumatology Board and is currently its Chair. She is also the Chair of the ABIM Rheumatology Board Exam Committee, serves as a member of the ABIM Council and is the incoming Chair of the ABIM Exam Chairs Committee. She is a member of the MGH Department of Medicine Education Council and Innovation in Education Committee. She previously served as the co-Chairperson for the Rheumatology In-Training Examination and on the ACR COTW, chairing the Sub-Committee on Resident Education, spearheading the development of “Rheum2Learn”, an online internal medicine resident education tool for rheumatology.

She obtained a bachelor of arts degree in chemistry and her medical degree from Duke University. She trained in internal medicine at the Eastern Virginia Graduate School of Medicine and obtained rheumatology training at MUSC.

As of January 2017, Dr. Bolster reported the following external relationships:

Clinical research, with funding for clinical trial expenses, clinical research staff and salary support, paid to Brigham and Women's Hospital and Massachusetts General Hospital, from the following company:

  • Eli Lilly & Co., to study the use of teriparatide in patients with rheumatoid arthritis to determine if it might help improve erosions.

Work funded by educational grants from industry, paid directly to Massachusetts General Hospital Rheumatology, from the following companies:

  • AbbVie, providing partial salary support for a rheumatology fellow; funding is used solely for a fellow's salary support.
  • Amgen, providing partial salary support for a rheumatology fellow through the Rheumatology Research Foundation; funding is used solely for a fellow's salary support.

Work as an author or editor for following companies, with compensation as listed:

  • Elsevier, receiving compensation as an editor for a volume of Rheumatic Disease Clinics of North America: Corticosteroids.
  • Merck Manual, receiving compensation as an author.

Susan Edgman-Levitan, PA

Ms. Edgman-Levitan is Executive Director of the John D. Stoeckle Center for Primary Care Innovation at Massachusetts General Hospital (MGH). Prior to coming to MGH, she was the founding President of the Picker Institute. She is a Lecturer in the Department of Medicine, Massachusetts General Hospital and an Associate in Health Policy, Harvard Medical School.

A constant advocate of understanding the patient's perspective on health care, Ms. Edgman-Levitan has been the co-Principal Investigator on the Harvard Consumer Assessment of Health Plans Study (CAHPS) from 1995 to the present and she is the Institute for Healthcare Improvement Fellow for Patient and Family-Centered Care. She is an editor of “Through the Patient's Eyes,” a book on creating and sustaining patient centered care, “The CAHPS Improvement Guide,” and has authored many papers and other publications on patient-centered care. She is a co-author of the Institute of Medicine 2006 report, The Future of Drug Safety: Promoting and Protecting the Health of the Public.

Ms. Edgman-Levitan serves on several boards and national advisory committees, including the Foundation for Informed Medical Decision Making, the National Patient Safety Foundation, the National Health Services Corps Advisory Council, the Patient-Centered Primary Care Collaborative, and is a member of the Lucian Leape Institute. She also serves on the American Board of Internal Medicine Council.

Ms. Edgman-Levitan is a graduate of the University of Michigan and the Duke University Physician Assistant program where she received the Distinguished Alumni award from the Duke Physician Assistant Program and was inducted into the Duke University Medical Center Hall of Fame in 2004. Ms. Edgman-Levitan was awarded the 2007 Leadership and Innovation award from the Center for Information Therapy.

As of January 2017, Ms. Edgman-Levitan reported the following external relationships:

Ms Edgman-Levitan serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • National Patient Safety Foundation, serving as a Board Member and member of the Lucian Leape Institute, receiving no compensation.
  • Patient-Centered Primary Care Collaborative, serving as a Board Member, receiving no compensation.
  • Healthwise, serving as a Board Member, receiving reimbursement for travel expenses and a per diem for attending board meetings.

Serpil C. Erzurum, MD

Dr. Erzurum is the Alfred Lerner Chair of the Department of Pathobiology in the Lerner Research Institute, and the Program Director of the Cleveland Clinic Clinical Research Unit of the Case Clinical Translational Science Center. In these roles, she led development of translational multidisciplinary research programs to investigate human diseases. Since 1993, she has practiced as an ABIM Board Certified pulmonologist at the Cleveland Clinic. She also holds certifications in internal medicine and critical care medicine.

Prior to the Cleveland Clinic, Dr Erzurum practiced at the University of Pittsburgh Medical Center, in the Indian Health Service in South Dakota, and as a senior staff fellow in the pulmonary branch of the National Heart Lung and Blood Institute (NHLBI). Over the past 25 years, her NIH-funded studies of asthma and pulmonary vascular diseases have uncovered mechanisms and led to new therapeutic concepts.

She is a member of the Board of External Experts and Board of Scientific Counselors for NHLBI, and a Councilor of the Association of American Physicians. Dr. Erzurum chairs the research committee of the Scientific Leadership Council of the Pulmonary Hypertension Association, and has been a senior fellow of the American Asthma Foundation. She is deputy editor of the American Journal of Respiratory and Critical Care Medicine since 2009. She serves on the American Board of Internal Medicine (ABIM) Council, is Chair of the ABIM Pulmonary Disease Board and is a member of the ABIM Pulmonary Disease Board Exam Committee.

Dr. Erzurum received her medical degree in 1983 from Northeastern Ohio Universities College of Medicine. Following medicine residency at Baylor College of Medicine, she trained in pulmonary and critical care at the University of Colorado and National Jewish Center.

As of January 2017, Dr. Erzurum reported no external relationships.

Joseph C. Farmer, MD

Dr. Farmer is a board certified internist and critical care physician. He serves as Professor and Chair, Department of Critical Care Medicine, Mayo Clinic Arizona. He previously served at Mayo Clinic in Rochester, Minnesota as Critical Care Medicine Fellowship Program Director, Associate Dean, Mayo School of Graduate Medical Education, and Associate Chair for Education, Department of Medicine.

Dr. Farmer is a retired Air Force Colonel and Professor of Medicine and Surgery, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine. He also served as a senior physician executive in the hospital, health plans-insurance, supply chain management and homeland security sectors. He is one of the founders of the Department of Defense Critical Care Aeromedical Transport Team program, the largest critical care transport system in the world. While in the Air Force, Dr. Farmer served as Chief of Inpatient Services at Wilford Hall Medical Center, and as Chief Medical Officer for TRICARE Southwest, a multi-state federal HMO. He also served as the Special Assistant to the Air Force Surgeon General for Homeland Defense and Medical Preparedness.

Dr. Farmer is a member of the American Board of Internal Medicine (ABIM) Critical Care Medicine Board and serves on the ABIM Critical Care Medicine Self-Assessment Committee. He was the 2014 President of the Society of Critical Care Medicine (SCCM) and has served as SCCM Council Member and Treasurer, Program Chair, SCCM Congress, Founding Editor-in-Chief, Multidisciplinary Critical Care Knowledge Assessment Program, Supplements Editor, Critical Care Medicine, and textbook editor, Fundamental Critical Care Support and Fundamental Disaster Management programs. He is the editor and author of numerous books related to critical care, education and disaster medical response.

Dr. Farmer holds a bachelor's degree in biology from Texas A&M University, where he also earned his medical degree. He completed residency at Wilford Hall Medical Center in the United States Air Force and a fellowship in critical care medicine at St. Louis University and St. Johns Mercy Medical Center.

As of January 2017, Dr. Farmer reported the following external relationships::

Funding for study expenses, paid to the Mayo Clinic, from the following companies:

  • Becton Dickinson, for a pilot program in Rwanda aimed at improving sepsis care in resource-limited nations.

Works as an author or editor for the following companies, with compensation as listed:

  • Oxford University Press, receiving compensation for authorship.

Marianne M. Green, MD

Dr. Green, board certified in internal medicine, is Senior Associate Dean for Medical Education at the Northwestern University Feinberg School of Medicine.

Over the course of her career, she has led several education initiatives, most recently as Administrative Leader for the Competency-Based Education Initiative, and has received numerous awards and honors, including the Harvard Macy Fellowship for Assessment in Medical Education and the George H. Joost Outstanding Teacher Award. Dr. Green is also an inaugural member of the Feinberg Academy of Medical Educators. In addition to her academic roles, Dr. Green directs patient care at the outpatient General Internal Medicine Clinic. She has authored multiple papers related to undergraduate medical education, and is a reviewer for several medical journals including JAMA, Archives of Internal Medicine and Annals of Internal Medicine.

Dr. Green serves as Chair of American Board of Internal Medicine (ABIM)'s Internal Medicine Board. She is a member of the ABIM Council and of its Board of Directors. She is on the Liebman Scholarship Selection Committee for Northwestern University as well as the Augusta Webster Grant for Educational Intervention Selection Committee.

She received her medical degree from the University of Illinois, Chicago School of Medicine and went on to complete her internship and residency at Beth Israel Hospital, Harvard Medical School.

As of January 2017, Dr. Green reported no external relationships.

Bruce A. Leff, MD

Dr. Leff is a board certified internist and geriatrician and Professor of Medicine at the Johns Hopkins University School of Medicine in the Division of Geriatric Medicine and Gerontology. He holds a joint appointment in the Department of Health Policy and Management at the Johns Hopkins University Bloomberg School of Public Health, and in the Johns Hopkins School of Nursing, Department of Community and Public Health.

He is the Director of the Center on Aging and Health Program in Geriatric Health Services Research and the co-Director of the Elder House Call Program. His principal areas of health services research relate to the development, evaluation and dissemination of innovative models of health service delivery for older adults, issues related to the care of people with multiple chronic conditions, the development of quality indicators for home-based medical care, guideline development and case-mix issues. He is the author of more than 100 peer-reviewed publications and book chapters. Dr. Leff has a strong interest in health policy and is a recent health and aging policy fellow and has served on multiple National Quality Forum and Centers for Medicare & Medicaid Services Technical Expert Panels. Dr. Leff cares for patients in the acute, ambulatory and home settings.

A member of the American Board of Internal Medicine (ABIM)'s Council, Dr. Leff is Chair of the ABIM Geriatric Medicine Board. He directs the medicine clerkship at the Johns Hopkins University School of Medicine and has received multiple awards for his teaching and mentorship. He is a member of the Board of Regents of the American College of Physicians, as well as past-President and current board member of the American Academy of Home Care Physicians.

Dr. Leff received his medical degree from the New York University School of Medicine and completed residency in primary care internal medicine at the Johns Hopkins Bayview Medical Center, and a fellowship in geriatric medicine and gerontology at the Johns Hopkins University School of Medicine, in Baltimore.

As of January 2017, Dr. Leff reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Johns Hopkins University, from the following company:

  • National Institutes of Health (NIH), trial of a non-drug intervention for patients with dementia.

Work as an author or editor for the following company, with compensation as listed:

  • Springer Publishing, Co-Editor of book on geriatric home-based medical care.

Dr. Leff holds a license on Hospital at Home, with income related to licensing technical materials to health systems, receiving royalties.

Dr. Leff serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Alliance for Home Health Quality and Innovation, Member of Board of Directors, receiving reimbursement for travel.
  • American Academy of Home Care Physicians, Member of Board of Directors, receiving reimbursement for travel.
  • Ascension Health, Member of the Quality Committee to the Board of Directors, receiving reimbursement for travel.
  • Community Health Accreditation Partner, Advisor on creating standards for home-based palliative care practices, receiving reimbursement for travel.
  • Kendal Corporation, Member of Board of Directors of Kendal Research, receiving no compensation.
  • Landmark Health, LLC, serving on the advisory board of a not-for-profit home health care company, receiving reimbursement for travel expenses and honoraria.
  • Measure Applications Partnership, Member of Post-Acute Care/Long-term Care Workgroup, receiving reimbursement for travel expenses.
  • National Quality Forum, Member of Measure Application Partnership Post-Acute and Long Term Care Committee, receiving reimbursement for travel.
  • Veterans Affairs, Member of the VA Geriatrics and Gerontology Advisory Committee, receiving reimbursement for travel.

Dr. Leff reported receiving grant funding from The Commonwealth Fund, The Retirement Research Fund, the John A. Hartford Foundation, Patient-Centered Outcomes Research Institute, National Institute of Aging, and California Healthcare Foundation, all paid to Johns Hopkins University.

Lesley A. Meng, MD

Dr. Meng is a native New Orleanian who was displaced by Hurricane Katrina, and though she was successfully practicing medicine in Scottsdale, Arizona, she desperately wanted to return and rebuild her practice in Louisiana. Her commitment to her patients is remarkable. She is a board certified medical oncologist who takes pride in seeing patients often within 24 hours of their initial phone call. She has done a great deal of cancer research and believes strongly in preventive and screening programs.

In May 2005, a year after finishing her fellowship in hematology/oncology, Dr. Meng opened a two-location solo practice in New Orleans. In August 2005, Hurricane Katrina washed it all away. She relocated to Scottsdale, Arizona and started over. There, she founded Desert Springs Cancer Care and designed and built a comprehensive care center. She had a successful practice and enjoyed Scottsdale, but, in 2012, decided to return to New Orleans.

She is now a hospital-employed physician and member of the East Jefferson General Hospital (EJGH) Physician Group. EJGH is a 420-bed not-for-profit community hospital. Extremely active in the community, Dr. Meng is committed to EJGH and providing the most innovative and effective, and highest levels of cancer care possible.

She is a member of the Pharmacy and Therapeutics Committee at EJGH and is involved with the design and development of a new cancer suite at EJGH. She has served on the utilization review committee, participated in the Oncology Survivorship Program, and is the clinical trial coordinator for the Physician Network at EJGH. In Arizona, she was on the board of the Arizona Foundation for Medical Care, the board of the Arizona State Physicians Association, the Arizona Regulatory Board of Physician Assistants, and the physician advisory board for Paradise Valley Hospital. Dr. Meng is also a member of the American Board of Internal Medicine Council.

She earned a bachelor's degree in biochemistry from Louisiana State University, and her medical degree from Louisiana State University Medical Center, where she completed an internal medicine internship, residency and fellowship training in hematology oncology.

As of January 2017, Dr. Meng reported no external relationships.

Michael R. Nelson, MD

Dr. Nelson, board certified in Allergy and Immunology by the American Board of Allergy and Immunology, is Director of the Medical Education Directorate for the U.S. Army Office of the Surgeon General and Allergist-Immunologist at the Walter Reed National Military Medical Center.

His other roles include Treasurer of the American Board of Allergy and Immunology and Liaison to the American Board of Internal Medicine Council, Chair of the Federal Drug Administration's Allergenic Products Advisory Committee, member and Chair of the Milestone Committee for the Accreditation Council for Graduate Medical Education Allergy-Immunology Review Committee, and Professor of Medicine and Pediatrics for the Uniformed Services University of the Health Sciences. He has authored numerous manuscripts and maintains a special interest in medical education, allergen immunotherapy, vaccine immune response and adverse effects.

Dr. Nelson received his medical degree and doctor of philosophy in pharmacology from the University of Virginia, where he also completed his internship in internal medicine. He went on to serve his residency at the Eisenhower Army Medical Center and later completed allergy/immunology and clinical laboratory fellowships at the Walter Reed National Military Medical Center. He has served as the Allergy-Immunology Consultant to the U.S. Army Office of the Surgeon General, Program Director for the National Capital Consortium Allergy-Immunology Fellowship, and Department Chair of Allergy-Immunology at both Walter Reed Army Medical Center and Walter Reed National Military Medical Center.

View my board certification status via ABMS Website

As of January 2017, Dr. Nelson reported the following external relationships:

Dr. Nelson serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American Academy of Allergy, Asthma & Immunology, serving as Chair of the Immunotherapy, Allergen Standardization and Allergy Diagnostics Committee, without compensation.
  • American Board of Allergy and Immunology, serving as President-Elect, receiving reimbursement for travel expenses and honoraria.
  • Accreditation Council for Graduate Medical Education (ACGME), serving as a member of the Allergy-Immunology Residency Review Committee, receiving reimbursement for travel expenses.

Dr. Nelson serves as Chair of the Allergenic Products Advisory Committee for the Food and Drug Administration (FDA).

Jane E. Onken, MD

Dr. Onken is an Associate Professor of Medicine, Division of Gastroenterology at Duke University Medical Center. She is Director of the Inflammatory Bowel Disease clinic at Duke and on faculty at the Duke Clinical Research Institute. She is board certified in Gastroenterology.

Dr. Onken is Chair of the American Board of Internal Medicine Gastroenterology Board and a member of the ABIM Council. She recently completed a three-year term as Chair of the Education and Training Committee of the American Gastroenterological Association (AGA). During that term, she served on the AGA’s Leadership Cabinet, the MOC Task Force, and the board of the Academy of Educators. She has chaired the AGA Training Subcommittee and been a member of the Graduate Training Examination Subcommittee. In 2013, she was selected to join the multi-society Oversight Working Network Committee, a group that designed the Entrustable Professional Activities currently in use by training programs in Gastroenterology. At Duke, she was recently elected for a fourth term to the University's Academic Council and has served on the Executive Committee of the Academic Council. Dr. Onken is a former program director for the Duke Gastroenterology Fellowship program. She is a member of the Leadership Board of the Triangle Chapter of the Crohn’s and Colitis Foundation of America (CCFA) and is a recipient of the CCFA Premier Physician Award.

Dr. Onken received her undergraduate degree from Smith College and attended the George Washington University School of Medicine. She completed her house staff training in internal medicine at Duke University, followed by fellowship training in gastroenterology. She received a master’s degree in health sciences from Duke in 2005.

As of January 2017, Dr. Onken reported the following external relationships:

Funding for clinical trial expenses, staff and salary support, paid to Duke University, from the following companies:

  • Seres Therapeutics, for a study investigating fecal replacement for patients with mild-to-moderate ulcerative colitis.

Dr. Onken serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American Gastroenterological Association, Chair of Education and Training Committee, Member of Leadership Cabinet, Board Member of Academy of Educators, receiving reimbursement for travel expenses.

Dana Safran, ScD

Dr. Safran is Senior Vice President for Performance Measurement and Improvement at Blue Cross Blue Shield of Massachusetts (BCBSMA). In this role, she leads the company's initiatives to measure and improve health care quality, safety and outcomes. Dr. Safran was among the lead developers of the BCBSMA Alternative Quality Contract, a provider contract model launched in 2009 with the twin goals of improving quality and outcomes while significantly slowing spending growth.

Dr. Safran also retains an active academic practice, as a faculty member in the Department of Medicine at Tufts University School of Medicine, and has authored more than 75 peer-reviewed articles.

She is widely recognized as having contributed to the empirical basis for our nation's push toward a more patient-centered health care system – and for developing measures of patient care experiences that are now used nationwide, accepted as a national standard for this area of measurement, and used by the medical boards as part of their recertification process for physicians.

Dr. Safran's advisory roles on national and local quality measurement include work with the Office of the National Coordinator, the Centers for Medicare & Medicaid Services, the National Quality Forum, the National Committee for Quality Assurance and the Massachusetts State Quality Advisory Council. She serves on the Board of Directors for the Blue Cross Blue Shield Foundation, Nurtury Early Care and Education, Massachusetts Health Quality Partners, on the Executive Committee for the Health Care Transformation Task Force, the American Board of Internal Medicine Council, and the Editorial Board of Healthcare: The Journal of Delivery Science and Innovation.

As of January 2017, Dr. Safran reported the following external relationships:

Dr. Safran serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Blue Cross Blue Shield of Massachusetts Foundation, Board Member, receiving reimbursement for travel.

Dr. Safran also serves on the Consensus Standards Advisory Committee (CSAC) of the National Quality Forum. She also serves on Massachusetts-Statewide Quality Advisory Committee.

Robert D. Siegel, MD

Dr. Siegel, a board certified internist, hematologist and medical oncologist is the Oncology Program Director for the Bon Secours St. Francis Health System in Greenville, South Carolina. Prior to his appointment to program leadership at St. Francis, Dr. Siegel had been a community based oncologist with particular interest in quality improvement initiatives and cancer care delivery research.

Dr. Siegel has served the ABIM as a member of the Medical Oncology Exam Writing Committee and is currently a member of the Specialty Board in Medical Oncology. In July, 2015, he was elected to serve on the ABIM Board of Directors. He has previously served as the Co-Chair of the Quality of Care Subcommittee for the NCI Community Cancer Centers Program (NCCCP) and is currently on the Executive Committee for SCOR (Southeast Consortium for Oncology Research).

Dr. Siegel earned his medical degree at the Columbia University College of Physicians and Surgeons and did his internal medicine training at Barnes Hospital/Washington University in St. Louis. He completed his fellowship training in medical oncology and hematology at the Dana Farber Cancer Institute/ Brigham and Women's Hospital/ Harvard University.

As of April 2017, Dr. Siegel reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Bon Secours St. Francis Hospital, from the following companies

  • Bristol-Myers Squibb, for a lung cancer clinical trial, kidney cancer clinical trial, and for a non-Hodgkin lymphoma clinical trial.
  • Cancer Insight, for a melanoma clinical trial.
  • Celgene, for two lymphoma clinical trials.
  • ImmunoGen, Phase II study of the efficacy and tolerability of IMGN529 in combination with rituximab in patients with relapsed and/or refractory diffuse large B-cell lymphomas and other non-Hodgin’s lymphomas.
  • Merck, for clinical trials for head and neck carcinoma, colorectal carcinoma, breast carcinoma, lymphoma, and two stomach cancer clinical trials.
  • Mirati Therapeutics, for a clinical trial for solid tumors.
  • Onyx, for a multiple myeloma clinical trial.
  • Pharmatech, for a metastatic colon cancer clinical trial.
  • ProNAi, for a lymphoma clinical trial.
  • TG Therapeutics, for a chronic lymphocytic leukemia clinical trial.
  • Biodesix, for an observational study assessing the clinical effectiveness of validating immunotherapy tests in subject with non-small cell lung cancer.
  • CerRX Inc., for a Phase II trial of intravenous fenretinide emulsion for patients with relapsed/refractory peripheral T-cell lymphomas.
  • Boston Biomedical, for a Phase II trial of metastatic pancreatic ductal adenocarcinoma.
  • GRAIL, Inc., for a trial of use deep sequencing of circulating cell-free nucleic acids to develop assays to detect cancer early in blood.

Dr. Siegel serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American Society for Clinical Oncology, Chair of Quality Oncology Practice Initiative Certification Oversight Committee, Member of Maintenance of Certification Task Force, receiving reimbursement for travel expenses.
  • Dr. Siegel also serves on the Advisory Committee for Wellpoint Oncology Clinical Pathways Development, receiving reimbursement for travel expenses and honoraria for his service.

Mark M. Udden, MD

Dr. Udden, a board certified hematologist and internist, is Chief of Benign Hematology and Professor of Medicine at Baylor College of Medicine (BCM) in Houston, Texas. He is Chief of Hematology at the Ben Taub General Hospital and Harris Health Smith Clinic. He is also an Attending Physician in the Baylor Clinic and consults at Baylor Saint Luke’s Medical Center and the Texas Children’s Hospital Pavilion for Women. He has a special interest in sickle cell disease and hematology of pregnancy. He also co-chairs the second-year medical student course in hematology/oncology and has an active teaching role for resident and fellowship training at Baylor.

He has served at Baylor as Core Clerkship Director for Internal Medicine from 1990 to 2007 and Chairman of the Longitudinal Ambulatory Care Experience course from 1994 to 1999. He was an adjunct Assistant then Associate Professor in the Biomedical Engineering Department at Rice University from 1983 until 1992.

Dr. Udden is Chair of the American Board of Internal Medicine (ABIM) Hematology Board. He is also Chair of the ABIM Hematology Board Exam Committee. He is a fellow of the American College of Physicians. At Baylor, he has received numerous teaching awards including the Barbara and Corbin J. Robertson, Jr. Presidential Award for Excellence in Education in 2008 and the Master Clinician Lifetime Award in 2013.

He received his undergraduate degree from the Massachusetts Institute of Technology and his medical degree from The University of Texas Southwestern Medical School. He completed his residency in internal medicine and a fellowship in hematology at Baylor College of Medicine.

As of January 2017, Dr. Udden reported the following external relationships:

Funding for clinical trial salary support, paid to Baylor College of Medicine, from the following company:

  • Sanofi, for a trial of leukine in dementia.

Jeffrey G. Wiese, MD

Dr. Wiese, who is board certified in Internal Medicine, is currently a Professor of Medicine and Associate Dean of Graduate Medical Education at Tulane University.

Dr. Wiese has written more than 60 articles, books or book chapters, and is a reviewer or editorial board member for a number of medical journals. An award-winning instructor at Tulane University, Dr. Wiese has received more than 30 awards for teaching, including the prestigious all-Tulane Faculty of the Year Award and the Virginia Furrow Award for Innovation in Medical Education. In 2005, he was awarded the Society of Hospital Medicine (SHM) national Award for Excellence in Teaching.

The main areas of professional interest for Dr. Wiese include health care reform, medical education and hospital finance/management. Additionally, Dr. Wiese was President of SHM in 2010. He is the former Chair and a current member of the American Board of Internal Medicine (ABIM) Hospital Medicine Exam-Writing Committee. He is also a member of the ABIM Council.

Dr. Wiese earned his bachelor's degree from Drake University in Des Moines, Iowa, and his medical degree from The Johns Hopkins School of Medicine. He went on to complete an internal medicine residency at the University of California, San Francisco, where he later completed a medical education fellowship.

As of January 2017, Dr. Wiese reported the following external relationships:

Work as an author or editor for following companies, with compensation as listed:

  • American College of Physicians (ACP), receiving royalties for the textbook, “Teaching in the Hospital.”

William F. Young Jr., MD

Dr. Young, a board certified internist and endocrinologist, is the Tyson Family Endocrinology Clinical Professor, and Chair of the Division of Endocrinology, Diabetes, Metabolism, and Nutrition at the Mayo Clinic in Rochester, MN. He is a practicing endocrinologist with an active clinical practice and a dedicated teacher and mentor to residents and endocrinology fellows.

Currently, Dr. Young serves as a member of the American Board of Internal Medicine (ABIM) Council and the ABIM Endocrinology Board Exam Committee, and he serves as Chair of the ABIM Endocrinology, Diabetes, and Metabolism Board. Dr. Young is an internationally recognized endocrinologist who has served as past President of the Endocrine Society, past Chair of the Endocrine Society Self-Assessment Committee, an Associate Editor for the Journal of Clinical Endocrinology and Metabolism, and as a Senior Editor for Clinical Endocrinology. He is past Chair of the Endocrine Society's Annual Meeting Steering Committee and Nominating Committee. Dr. Young has published more than 240 articles on endocrine hypertension and adrenal and pituitary disorders. He has been the recipient of multiple education awards and has presented at over 300 national and international meetings and he has been an invited visiting professor for more than 100 medical institutions.

As of May 2017, Dr. Young reported the following external relationships:

Funding for preclinical trial expenses and staff from the following company:

  • Nihon-Medi Physics, for animal studies to determine new approach to imaging the adrenal glands with PET-based technologies, receiving consulting fees.

Work as an author or editor for following companies, with compensation as listed:

  • UpToDate, receiving compensation for authorship.
  • Elsevier, receiving compensation for authorship for the book, The Netter Collection of Medical Illustrations: Endocrine System.
  • Wiley-Blackwell, receiving compensation for authorship.

Dr. Young serves in a significant role with the following organizations, receiving reimbursement or compensation as listed:

  • International Society of Endocrinology, serving as an Executive Board Member, without compensation.